C-RAD AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0002016352
SEK
31.25
-2.9 (-8.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Negative results in Jun 25

  • INTEREST(HY) At SEK 21 MM has Grown at 356.52%
  • PRE-TAX PROFIT(Q) At SEK 5.1 MM has Fallen at -62.22%
  • NET PROFIT(Q) At SEK 4 MM has Fallen at -62.26%
2

With ROE of 7.56%, it has a expensive valuation with a 3.22 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 1,115 Million (Small Cap)

stock-summary
P/E

43.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.49

stock-summary
Return on Equity

6.55%

stock-summary
Price to Book

3.14

Revenue and Profits:
Net Sales:
105 Million
(Quarterly Results - Jun 2025)
Net Profit:
4 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.64%
0%
0.64%
6 Months
1.13%
0%
1.13%
1 Year
-29.22%
0%
-29.22%
2 Years
7.57%
0%
7.57%
3 Years
-30.63%
0%
-30.63%
4 Years
-44.1%
0%
-44.1%
5 Years
3.82%
0%
3.82%

C-RAD AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
18.21%
EBIT Growth (5y)
82.28%
EBIT to Interest (avg)
29.86
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.49
Sales to Capital Employed (avg)
1.47
Tax Ratio
39.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
32.53%
ROE (avg)
10.39%
Valuation key factors
Factor
Value
P/E Ratio
43
Industry P/E
Price to Book Value
3.22
EV to EBIT
13.38
EV to EBITDA
11.95
EV to Capital Employed
5.13
EV to Sales
2.11
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
38.32%
ROE (Latest)
7.56%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -18.70% vs 42.83% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -62.26% vs 96.30% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "105.20",
          "val2": "129.40",
          "chgp": "-18.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.20",
          "val2": "20.00",
          "chgp": "-39.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.30",
          "val2": "4.40",
          "chgp": "-25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.00",
          "val2": "10.60",
          "chgp": "-62.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "92.20%",
          "val2": "147.60%",
          "chgp": "-5.54%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 10.46% vs 40.92% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 58.87% vs 373.33% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "469.00",
          "val2": "424.60",
          "chgp": "10.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "74.10",
          "val2": "53.60",
          "chgp": "38.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.40",
          "chgp": "-25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "56.40",
          "val2": "35.50",
          "chgp": "58.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "149.80%",
          "val2": "115.40%",
          "chgp": "3.44%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
105.20
129.40
-18.70%
Operating Profit (PBDIT) excl Other Income
12.20
20.00
-39.00%
Interest
3.30
4.40
-25.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
4.00
10.60
-62.26%
Operating Profit Margin (Excl OI)
92.20%
147.60%
-5.54%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is -18.70% vs 42.83% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -62.26% vs 96.30% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
469.00
424.60
10.46%
Operating Profit (PBDIT) excl Other Income
74.10
53.60
38.25%
Interest
0.30
0.40
-25.00%
Exceptional Items
0.10
0.20
-50.00%
Consolidate Net Profit
56.40
35.50
58.87%
Operating Profit Margin (Excl OI)
149.80%
115.40%
3.44%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 10.46% vs 40.92% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 58.87% vs 373.33% in Dec 2023

stock-summaryCompany CV
About C-RAD AB stock-summary
stock-summary
C-RAD AB
Pharmaceuticals & Biotechnology
C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.
Company Coordinates stock-summary
Company Details
Bredgrand 18 , UPPSALA None : 753 20
stock-summary
Tel: 46 18 666930
stock-summary
Registrar Details